Scientists say eye-disease drug may also help fight COVID
Research brief: In a lab study, a UCLA-led team found that verteporfin stopped the replication of SARS-CoV-2, the virus that causes COVID-19.
Stay updated with breaking news from Research Award Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Research brief: In a lab study, a UCLA-led team found that verteporfin stopped the replication of SARS-CoV-2, the virus that causes COVID-19.
Women with COVID in pregnancy who are subsequently vaccinated after recovery, but prior to delivery, are more likely to pass antibodies on to the child than similarly infected but unvaccinated mothers are.
Company operating well through unprecedented global economic headwinds and continued impacts of COVID-19 variants in certain markets Q2'22 total revenues
Press release content from Business Wire. The AP news staff was not involved in its creation.
The findings suggested that viral polymerase could potentially be added to vaccines to create a longer-lasting immune response